Company Filing History:
Years Active: 2022
Title: Innovations by Jean Daniel Brion in NMDA Receptor Modulation
Introduction
Jean Daniel Brion is an innovative inventor based in Saint Leu la Foret, France. He has made significant contributions to the field of neuroscience, particularly in the development of compounds that target NMDA receptors in the central nervous system. His work aims to address various diseases that affect cognitive function and overall brain health.
Latest Patents
Jean Daniel Brion holds a patent for NMDA receptor modulators, which includes compositions and their use in treating diseases involving the central nervous system. The patent specifically relates to compounds of the type 1-(indol-3-yl)-3-hydroxy-3-(2-oxo-2-ethyl)-indol-2-ones. These compounds are intended for use in pharmaceutical compositions aimed at preventing or treating conditions such as severe epilepsy, cognitive disorders, strokes, schizophrenia, and degenerative diseases like Parkinson's and Alzheimer's. His innovative approach has the potential to significantly impact the treatment landscape for these challenging conditions.
Career Highlights
Jean Daniel Brion is associated with Adpuerivitam, where he continues to advance his research and development efforts. His focus on NMDA receptor modulation showcases his commitment to finding effective solutions for complex neurological disorders. With a patent portfolio that includes 1 patent, he is recognized for his contributions to the field.
Collaborations
Throughout his career, Jean Daniel Brion has collaborated with talented individuals such as Mouad Alami and Samir Messaoudi. These partnerships have fostered a collaborative environment that enhances the innovation process and drives forward the research initiatives at Adpuerivitam.
Conclusion
Jean Daniel Brion's work in NMDA receptor modulation represents a significant advancement in the treatment of central nervous system diseases. His innovative compounds and dedication to research have the potential to improve the lives of many individuals affected by neurological disorders.